These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
572 related items for PubMed ID: 14636202
1. Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Behçet's syndrome. Cekmen M, Evereklioglu C, Er H, Inalöz HS, Doganay S, Türköz Y, Ozerol IH. Int J Dermatol; 2003 Nov; 42(11):870-5. PubMed ID: 14636202 [Abstract] [Full Text] [Related]
2. Serum leptin concentration is increased in patients with Behçet's syndrome and is correlated with disease activity. Evereklioglu C, Inalöz HS, Kirtak N, Doganay S, Bülbül M, Ozerol E, Er H, Ozbek E. Br J Dermatol; 2002 Aug; 147(2):331-6. PubMed ID: 12174107 [Abstract] [Full Text] [Related]
3. Serum homocysteine level is increased and correlated with endothelin-1 and nitric oxide in Behçet's disease. Er H, Evereklioglu C, Cumurcu T, Türköz Y, Ozerol E, Sahin K, Doganay S. Br J Ophthalmol; 2002 Jun; 86(6):653-7. PubMed ID: 12034688 [Abstract] [Full Text] [Related]
4. Increased plasma adrenomedullin levels in patients with Behçet's disease. Evereklioglu C, Yurekli M, Er H, Ozbek E, Hazneci E, Cekmen M, Inaloz HS. Dermatology; 2000 Jun; 201(4):312-5. PubMed ID: 11146340 [Abstract] [Full Text] [Related]
5. Urinary adrenomedullin levels are increased and correlated with plasma concentrations in patients with Behçet's syndrome. Evereklioglu C, Ozbek E, Er H, Cekmen M, Yürekli M. Int J Urol; 2002 Jun; 9(6):296-303. PubMed ID: 12110092 [Abstract] [Full Text] [Related]
6. The relationship of serum VEGF and sVEGFR-1 levels with vascular involvement in patients with Behçet's disease. Sertoglu E, Omma A, Yucel C, Colak S, Sandıkcı SC, Ozgurtas T. Scand J Clin Lab Invest; 2018 Oct; 78(6):443-449. PubMed ID: 30015524 [Abstract] [Full Text] [Related]
7. The significance of immunohistochemistry in the skin pathergy reaction of patients with Behçet's syndrome. Inaloz HS, Evereklioglu C, Unal B, Kirtak N, Eralp A, Inaloz SS. J Eur Acad Dermatol Venereol; 2004 Jan; 18(1):56-61. PubMed ID: 14678533 [Abstract] [Full Text] [Related]
8. Decreased nitric oxide production in patients with Behçet's disease. Orem A, Vanizor B, Cimşit G, Kiran E, Değer O, Malkoç M. Dermatology; 1999 Jan; 198(1):33-6. PubMed ID: 10026399 [Abstract] [Full Text] [Related]
9. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease. Evereklioglu C, Er H, Türköz Y, Cekmen M. Mediators Inflamm; 2002 Apr; 11(2):87-93. PubMed ID: 12061429 [Abstract] [Full Text] [Related]
10. The Evaluation of the Relationship between sTREM-1, VEGF-B, and VEGF Gene Expression Levels with Disease Activity of Behçet's Patients. Harmanci K, Akan OY, Pirildar T, Ortan P, Ulman C. Dis Markers; 2018 Apr; 2018():2649392. PubMed ID: 30420902 [Abstract] [Full Text] [Related]
11. Vascular endothelial growth factor and monocyte chemoattractant protein-1 in Behçet's patients with venous thrombosis. Bozoglu E, Dinc A, Erdem H, Pay S, Simsek I, Kocar IH. Clin Exp Rheumatol; 2005 Apr; 23(4 Suppl 38):S42-8. PubMed ID: 16273763 [Abstract] [Full Text] [Related]
12. Vascular endothelial and basic fibroblast growth factor serum levels in patients with Behçet's disease. Erdem F, Gündoğdu M, Kiki I, Ali Sari R, Kiziltunç A. Rheumatol Int; 2005 Oct; 25(8):599-603. PubMed ID: 15257411 [Abstract] [Full Text] [Related]
13. Synovial nitric oxide concentrations are increased and correlated with serum levels in patients with active Behçet's disease: a pilot study. Duygulu F, Evereklioglu C, Calis M, Borlu M, Cekmen M, Ascioglu O. Clin Rheumatol; 2005 Aug; 24(4):324-30. PubMed ID: 15902528 [Abstract] [Full Text] [Related]
14. Adamantiades-Behçet's disease: interleukin-8 is increased in serum of patients with active oral and neurological manifestations and is secreted by small vessel endothelial cells. Zouboulis CC, Katsantonis J, Ketteler R, Treudler R, Kaklamani E, Hornemann S, Kaklamanis P, Orfanos CE. Arch Dermatol Res; 2000 Jun; 292(6):279-84. PubMed ID: 10929768 [Abstract] [Full Text] [Related]
15. Soluble endothelial protein C receptor levels in Behçet patients with and without ocular involvement. Yalçindağ FN, Batioğlu F, Ozdemir O, Cansizoğlu E, Eğin Y, Akar N. Graefes Arch Clin Exp Ophthalmol; 2008 Nov; 246(11):1603-8. PubMed ID: 18604550 [Abstract] [Full Text] [Related]
16. Novel markers of endothelial dysfunction and inflammation in Behçet's disease patients with ocular involvement: epicardial fat thickness, carotid intima media thickness, serum ADMA level, and neutrophil-to-lymphocyte ratio. Yuksel M, Yildiz A, Oylumlu M, Turkcu FM, Bilik MZ, Ekinci A, Elbey B, Tekbas E, Alan S. Clin Rheumatol; 2016 Mar; 35(3):701-8. PubMed ID: 25744156 [Abstract] [Full Text] [Related]
17. Increased nitric oxide production in patients with Behçet's disease: is it a new activity marker? Evereklioglu C, Turkoz Y, Er H, Inaloz HS, Ozbek E, Cekmen M. J Am Acad Dermatol; 2002 Jan; 46(1):50-4. PubMed ID: 11756945 [Abstract] [Full Text] [Related]
18. The relationship between serum levels of angiogenin, bFGF, VEGF, and ocular involvement in patients with Behçet's disease. Yalçındağ A, Gedik-Oğuz Y, Yalçındağ FN. Graefes Arch Clin Exp Ophthalmol; 2013 Jul; 251(7):1807-12. PubMed ID: 23553285 [Abstract] [Full Text] [Related]
19. High levels of endothelial progenitor cells and circulating endothelial cells in patients with Behçet's disease and their relationship to disease activity. Arica DA, Akşan B, Örem A, Altinkaynak BA, Yayli S, Sönmez M. An Bras Dermatol; 2019 Jul 29; 94(3):320-326. PubMed ID: 31365661 [Abstract] [Full Text] [Related]
20. Value of hematological indices versus VEGF as biomarkers of activity in Behçet's disease. Gheita TA, Sakr BR, Rabea RE, Abd ElHamid SM. Clin Rheumatol; 2019 Aug 29; 38(8):2201-2210. PubMed ID: 30919148 [Abstract] [Full Text] [Related] Page: [Next] [New Search]